MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

Phase 3
Completed
Conditions
Angina Pectoris
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000510

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

Phase 2
Completed
Conditions
Hemoglobinopathies
Anemia (Iron-Loading)
Thalassemia
Hemochromatosis
Beta-Thalassemia
Hematologic Diseases
Iron Overload
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000595

Transfusion-Transmitted Cytomegalovirus Prevention in Neonates

Phase 3
Completed
Conditions
Blood Transfusion
Cytomegalovirus Infections
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000584

Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
Heart Diseases
Myocardial Infarction
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000503

Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Obesity
Heart Diseases
Hypertension
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000515

Hepatitis B Vaccine Clinical Trial

Phase 3
Completed
Conditions
Hepatitis B
Hepatitis, Viral, Human
Liver Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000583

Coronary Drug Project Mortality Surveillance

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Myocardial Infarction
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000483

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

Phase 3
Completed
Conditions
Hematologic Diseases
Pancytopenia
Anemia, Aplastic
Blood Disease
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000597

Lung Health Study (LHS) I and III

Phase 3
Completed
Conditions
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000568

Thrombolysis in Myocardial Infarction (TIMI)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000505
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy